coexisting β 1 AR and β 2 AR subtypes that exert opposing effects on cardiac cell survival and cell death (4, 5, 16) . In the present study, we demonstrate that β 1 AR-induced cardiac myocyte apoptosis is independent of cAMP and PKA signaling, but requires a novel signaling pathway involving Ca 2+ and Ca 2+ /calmodulin-dependent protein kinase II (CaMKII).
Methods
Materials. Isoproterenol (ISO); norepinephrine; prazosin; propranolol; cyclosporin A; FK506; ICI 118,551; H-89; pertussis toxin (PTX); nifedipine; and thapsigargin were purchased from Sigma-Aldrich (St. Louis, Missouri, USA). Rp-8-CPT-cAMPS (Rp-cAMP) was purchased from BIOLOG Life Science Institute (La Jolla, California, USA). PKI14-22 (PKI), autocamtide-2-related inhibitory peptide (AIP), KN93, and KN92 were purchased from Calbiochem-Novabiochem Corp. (La Jolla, California, USA).
Cardiac myocyte culture and adenoviral infection. Single cardiac myocytes were enzymatically isolated from the hearts of 2-to 3-month-old WT, β 2 AR KO, or β 1 β 2 DKO male mice, and then cultured. β 1 β 2 DKO and β 2 AR KO cells were infected with target gene-carrying adenoviral vectors as described previously (20) . Briefly, myocytes were plated at 0.5 × 10 4 to 1 × 10 4 cells per cm 2 with MEM containing 1.2 mM Ca 2+ and 1% penicillin-streptomycin in culture dishes precoated with 10 µg/ml mouse laminin. Adenovirus-mediated gene transfer was implemented by adding adenoviral vectors carrying either the mouse β 1 AR gene (Adv-β 1 AR), the marker gene β-gal (Adv-β-gal), or the βARK-ct gene (Adv-βARK-ct, kindly provided by R.J. Lefkowitz and W.J. Koch, Duke University, Durham, North Carolina, USA) to β 1 β 2 DKO cells. Alternatively, hemagglutinintagged (HA-tagged) CaMKII-δB vector (Adv-CaMKII-δB) or HA-tagged CaMKII-δC vector (Adv-CaMKII-δC) was added to β 2 AR KO cells. All transfections were at an MOI of 100. At the MOI used, almost 100% of myocytes were positively infected, as evidenced by β-gal staining (20) or GFP fluorescent signal (Adv-GFP infection, our unpublished data).
After adenoviral infection for 24 hours, culture medium was added with designated reagents, including PKA inhibitors (PKI or Rp-cAMP), CaMKII inhibitors (AIP, KN93, or KN93's inactive analogue, KN92) 1 hour prior to β 1 AR stimulation by ISO. In addition, calcineurin inhibitors (cyclosporin A or FK506), βAR antagonists (propranolol or ICI 118,551), or an L-type Ca 2+ channel antagonist (nifedipine), or a sarcoplasmic reticulum (SR) Ca 2+ pump inhibitor (thapsigargin) were added 1 hour prior to ISO treatment (1 µM) in some subsets of experiments. All apoptosis assays were performed after ISO treatment for 24 hours unless otherwise indicated. All dishes were supplemented with ascorbic acid (100 µM; Sigma-Aldrich) to prevent ISO oxidation.
TUNEL and Hoechst staining. Nuclear fragmentation was determined in fixed cells (70% alcohol and 30% acetone) either by incubating in 10 µM Hoechst 33342 or by TUNEL staining with apoptosis detection kits (R&D Systems Inc., Minneapolis, Minnesota, USA), as previously described (5) . The percentage of TUNEL-or Hoechst-positive cells was determined by counting 500-800 cardiac myocytes in 20 randomly chosen fields in each culture dish (with cells pooled from two to three hearts). (In Figure 1 , c and d, Figure 2 , Figure 4c , Figure 5b , and Figure 7c , all n values refer to the number of independent experiments, and each data point shows the result from 5,000-6,000 cells, n = 4-8.) As shown previously (5), the percentage of TUNEL-positive cells is lower than that of Hoechst-positive cells because some apoptotic myocytes are detached and washed away during the TUNEL staining assay.
DNA laddering and cell death ELISA. For DNA laddering, 10 µg of DNA was loaded in each lane. The DNA was size-fractionated on a 1.5% agarose gel in Tris-acetate-EDTA buffer and then stained with ethidium bromide (Life Technologies Inc., Carlsbad, California, USA).
For cell death ELISA, myocytes in each group were harvested by trypsinization and then combined with the cells pelleted from media. The cell pellets were washed with PBS and then split into two aliquots: one used for assay of protein abundance to normalize among samples, and the other for extraction of cytoplasmic DNA. DNA was assayed using a commercially available kit to measure nucleosomal DNA (Cell Death Detection ELISA Plus; Roche Molecular Biochemicals, Indianapolis, Indiana, USA). Specifically, 0.20 ml of lysis buffer was used for each aliquot of approximately 100,000 cells. Cells were lysed by gently dispersing the pellet using a pipette tip that was cut back to prevent shearing of cells and release of nuclear DNA. The extraction was performed at room temperature and took 30 minutes. The extract was then centrifuged at low speed and assayed according to the manufacturer's instructions. The control absorbance, measured in myocytes infected by Adv-β 1 AR, was considered as 100% or one unit. Fold increase was obtained by dividing the measured absorbance of an experimental group by the absorbance of the control. All measurements were normalized to the amount of total cellular protein. All measurements were made in triplicate and analysis was performed on at least four independent experiments.
Measurement of intracellular Ca 2+ . Cultured myocytes in the absence of electrical pacing were loaded with a fluorescent Ca 2+ probe, indo-1-acetoxymethyl ester (Molecular Probes Inc., Eugene, Oregon, USA), and were excited at 350 nm. The ratio (R) of fluorescence emission at 410 nm to that at 490 nm was used as an index of intracellular Ca 2+ , as described previously (22) . The intracellular free Ca 2+ concentration was calculated according to the equation [Ca 2+ 
where R min and R max are the ratio of fluorescence signal at 490 nm at zero and saturating [Ca 2+ ] i , respectively; β is a constant, and K d is the dissociation constant of the indicator. In addition, spatial properties of the caffeine-releasable SR Ca 2+ store were examined using an LSM410 confocal microscope (Carl Zeiss Jena GmbH, Jena, Germany) with UV laser excitation (351 nm) and dual wavelength ratiometric (410/490 nm) imaging. In another subset of experiments, intracellular Ca 2+ transients were measured in cultured myocytes electrically paced at 0.5 Hz.
Phospholamban Ser 16 phosphorylation, CaMKII autophosphorylation, and CaMKII activity assay. PKA-dependent phosphorylation of phospholamban (PLB) at Ser 16 was detected by Western blot using a site-specific antibody (Badrilla, West Yorkville, United Kingdom). Total CaMKII protein abundance was assayed by Western blot using an antibody reacting with total CaMKII (Santa Cruz Biotechnology Inc., Santa Cruz, California, USA), whereas autophosphorylated CaMKII was determined with a monoclonal antibody reacting with phosphorylated CaMKII (Affinity BioReagents Inc., Golden, Colorado, USA) (23) . CaMKII activity was evaluated with CaMKII assay kits (Upstate Biotechnology Inc., Lake Placid, New York, USA) and a peptide substrate (KKALRRQETVDAL) of the kinase.
Western blot analysis and confocal immunocytochemical imaging of HA-tagged CaMKII-δB or CaMKII-δC. Adenovirus-directed expression of HA-tagged CaMKII-δB or CaMKII-δC in β 2 AR KO cardiomyocytes was examined by Western blot with a monoclonal antibody reacting with HA (Covance Inc., Princeton, New Jersey, USA). To determine subcellular localization of CaMKII-δC, cells were incubated overnight at 4°C with the HA monoclonal antibody, followed by an incubation for 4 hours with a Texas Red-conjugated anti-mouse antibody (Vector Laboratories Inc., Burlingame, California, USA). Immunostaining was then visualized with a scanning confocal microscope (LSM510; Carl Zeiss Jena GmbH), as described previously (23) .
Statistical analysis. Data were expressed as mean ± SE. Statistical comparisons used one-way ANOVA followed by the Bonferroni procedure for multiple-group comparisons. P < 0.05 was considered statistically significant.
Results
Sustained β 1 AR stimulation delivers a potent apoptotic signal in cardiac myocytes. In β 1 β 2 DKO cells infected with an adenoviral vector encoding β 1 AR (Adv-β 1 AR) at an MOI of 100 for 24 hours, the β 1 AR density was 550 ± 46 fmol/mg protein (n = 4), which was approximately 16-fold greater than the receptor density in WT cells (33.5 ± 1.5 fmol/mg protein, n = 3). Stimulation of the expressed β 1 ARs by ISO (1 µM) for 24 hours caused cardiomyocyte death by increased apoptosis (Figure 1a ). Figure 2b ). These results validate the relevance of our data in DKO cells expressing β 1 AR using adenoviral gene transfer. Thus, sustained β 1 AR stimulation delivers a potent apoptotic signal, in agreement with previous reports (3-6). Since a similar maximal apoptotic effect occurred in all three experimental systems examined, the receptor density appears not to be a rate-limiting factor in transducing β 1 AR apoptotic signal in cardiac myocytes.
β 1 AR-induced apoptosis is independent of cAMP/PKA signaling. To determine the potential role of cAMP/PKA in β 1 AR-mediated myocyte apoptosis, we first used H-89, a widely used PKA inhibitor, and found that H-89 at a high concentration (20 µM) protected cardiac myocytes against β 1 AR-induced apoptosis. TUNEL-positive cells were reduced from 11.4% ± 1.1% to 3.3% ± 0.8% by H-89 (n = 4, P < 0.01), consistent with previous reports (12) . However, the interpretation of experiments using H-89 is complicated by the recent finding that H-89 is also a potent βAR blocker (24) . We therefore inhibited this pathway using a highly specific, membrane-permeable peptide PKA inhibitor, PKI (25) , and an inactive cAMP analogue, Rp-cAMP (26) . Pretreatment of myocytes with either Rp-cAMP (100 µM) or PKI (5 µM) completely abolished PKA-dependent phosphorylation of PLB (Figure 1b) , a key cardiac PKA target protein that regulates the SR Ca 2+ pump activity (27) , thus validating the effectiveness of these PKA inhibitors in abrogating cAMP/PKA signaling. Surprisingly, neither PKA inhibitor at the same respective concentrations had any significant effect on β 1 AR-mediated apoptosis ( Figure 1 , a and c-e, and Figure 5c ).
The inability of PKA inhibitors to protect cardiac myocytes against β 1 AR-induced apoptosis was confirmed in the β 2 AR KO model, in which the density and functionality of native β 1 ARs remain unaltered (19) , and in WT mouse myocytes subjected to ISO in the presence of β 2 AR blockade. Stimulation of the native β 1 AR in adult β 2 AR KO or WT cardiac myocytes by ISO similarly increased TUNEL-positive cells even in the presence of PKI or Rp-cAMP (Figure 2) . Thus, while the cAMP/PKA signaling pathway has been thought to be the sole mechanism responsible for β 1 -adrenergic responses, β 1 AR apoptotic signal transduction essentially bypasses this pathway.
Role of G βγ or G i signaling. To identify the molecular mediator for the non-PKA-dependent β 1 AR apoptotic effect, we tested several candidates, including free G βγ released from heterotrimeric G s proteins or G proteins other than G s (e.g., G i proteins). The possible involvement of G βγ or G i signaling in β 1 AR-mediated apoptosis was examined by adenoviral gene transfer of the C-terminal domain of βAR kinase (βARK-ct) to inhibit G βγ signaling (28) and by pretreatment of cells with PTX to disrupt G i signaling (29) . Neither βARK-ct nor PTX significantly affected β 1 AR-mediated apoptotic DNA fragmentation (Figure 3 ). In contrast, both interventions effectively blocked the G βγ -and G i -mediated β 2 AR antiapoptotic effect under similar experimental conditions (5) and prevented G βγ -mediated activation of PI3K (30) . These results rule out the possibility that G βγ or G i signaling is responsible for β 1 AR-mediated cardiomyocyte apoptosis.
Essential role of Ca 2+ entry and intracellular Ca 2+ in β 1 AR apoptotic signaling. It has been shown that altered Ca 2+ signaling promotes apoptosis in a variety of cell types (31) . We next explored the possibility that Ca 2+ , instead of cAMP, acts as the second messenger to transmit the β 1 AR apoptotic signal in cardiac myocytes. In Adv-β 1 AR-infected DKO myocytes, ISO treatment for 3-6 hours (just prior to manifestation of β 1 AR-induced apoptosis) significantly elevated intracellular free Ca 2+
620
The as measured with the Ca 2+ -sensitive fluorescent probe indo-1. As shown in Figure 4a , sustained β 1 AR stimulation increased basal cytosolic Ca 2+ from 122. (Figure 4c ). In addition, we measured SR Ca 2+ load, as indexed by the amplitude of Ca 2+ transients generated in response to a bolus administration of caffeine (20 µM). We found that sustained β 1 AR stimulation significantly elevated the caffeine-releasable SR Ca 2+ content, by 38% ( Figure 4, d and e) . Confocal imaging further revealed that the caffeine-induced Ca 2+ release was spatially uniform (at the optical resolution), regardless of β 1 AR stimulation (Figure 4d ). Paralyzing SR Ca 2+ recycling by inhibiting the SR Ca 2+ pump with thapsigargin also protected myocytes from β 1 AR-induced apoptosis (Figure 4c) (32, 33) , whereas its apoptotic effect is well established in other cell types (34) . The present data show that inhibition of calcineurin by cyclosporin A (5 µM) or FK506 (10 µM) failed to block β 1 ARinduced apoptotic heart cell death, suggesting that calcineurin does not play an essential role in β 1 AR apoptotic signaling (Figure 5b ).
In sharp contrast, a highly specific membrane-permeable peptide inhibitor of CaMKII, autocamtide-2-related inhibitory peptide (AIP, 10 µM) (35), fully protected myocytes from β 1 AR-induced apoptosis, as evidenced by the typical micrographs (Figure 5a ) and the average results of TUNEL staining (Figure 5b ). Similar protective effects were observed with another specific CaMKII inhibitor, KN93 (0.5 µM), but not its inactive analogue, KN92 (2 µM) ( Figure 5, a and b) . DNA laddering assays confirmed that β 1 AR-induced DNA fragmentation was resistant to the PKA inhibitor PKI, but suppressed by the CaMKII inhibitor KN93 (Figure 5c ). Moreover, in either β 2 AR KO or WT mouse cardiac myocytes, inhibition of CaMKII by AIP or KN93 similarly prevented β 1 AR-mediated apoptosis (Figure 2 ). Norepinephrine (at 1 µM), a physiological catecholamine, in the presence of an α 1 AR blocker, prazosin (1 µM), similarly promoted apoptosis in WT cells, an effect that activation of CaMKII, rather than PKA, is required for β 1 AR-induced apoptosis in the heart. The pivotal role of CaMKII in β 1 AR-mediated apoptotic signaling was reinforced by data on the pharmacological profile of β 1 AR-induced CaMKII activation. In Adv-β 1 AR-infected DKO cells, ISO stimulation for 6 hours increased the level of autophosphorylated CaMKII, an active form of the kinase (36) , without altering the abundance of the kinase protein ( Figure  6a) . Notably, the increase in CaMKII activity was PKIresistant, but was abolished by KN93 and AIP ( Figure  6 , a-c) at the same respective concentrations that blocked the β 1 AR-mediated apoptotic effect. Since CaMKII activity was elevated prior to the manifestation of cardiomyocyte apoptosis, we conclude that CaMKII activation constitutes an early β 1 AR-elicited event to signal cell apoptosis.
Overexpression of CaMKII-δC exaggerates β 1 AR-induced apoptosis. Based on the aforementioned results, an increase in CaMKII abundance should enhance the β 1 AR apoptotic effect in cardiac myocytes. To test this hypothesis, we expressed HA-tagged CaMKII-δC, a predominant cardiac cytoplasmic CaMKII isoform (37), or CaMKII-δB, a nuclear CaMKII isoform (37) , in β 2 AR KO myocytes. Confocal immunocytochemical analysis confirmed that the expressed CaMKII-δC was distributed in cytoplasm and the surface membranes, including the transverse tubules (Figure 7a, II and III) , but not in the nuclei (Figure  7a, III) , whereas CaMKII-δB was concentrated in the nuclei (Figure 7a, IV) . Expression of HA-tagged CaMKII-δC was also confirmed by Western blotting using a monoclonal antibody reacting with HA (Figure 7b) . Remarkably, overexpression of CaMKII-δC shifted the dose-response curve of ISOinduced apoptosis leftward by nearly an order of magnitude (EC 50 , 1.1 nM and 9.0 nM for myocytes infected by Adv-CaMKII-δC and Adv-β-gal, respectively) and increased the maximal apoptotic effect by 50%, whereas it exerted no appreciable apoptotic effect in the absence of β 1 AR stimulation by ISO (Figure 7c) . Again, inhibition of CaMKII by KN93 in cardiac myocytes overexpressing CaMKII-δC abolished the β 1 AR apoptotic effect over a wide range of agonist concentrations (Figure 7c ). By contrast, overexpression of CaMKII-δB neither enhanced nor reduced β 1 ARinduced myocyte apoptosis (data not shown), indicating that CaMKII-δC but not CaMKII-δB is involved in β 1 AR apoptotic signaling. The fact that increased CaMKII-δC abundance exaggerates the β 1 AR apoptotic effect without altering basal cell apoptosis substantiates the conclusion that CaMKII mediates the β 1 AR apoptotic signal. Discussion β 1 AR apoptotic signaling pathway. The prevalent theory of β 1 AR signal transduction is that the cAMP/PKA pathway is solely responsible for β 1 AR-mediated cellular responses. A close inspection of studies to date, however, reveals no convincing evidence to validate that this is also the case for β 1 AR-evoked apoptotic signal in the heart. Using two genetically defined β 1 AR systems, we have provided the first documentation that sustained β 1 AR stimulation delivers a powerful cardiac apoptotic signal via a CaMKII-dependent, rather than a PKAdependent, mechanism. This conclusion is based on several lines of evidence. First, inhibition of PKA by a specific peptide inhibitor, PKI, or an inactive cAMP analogue, Rp-cAMP, does not affect β 1 AR-induced myocyte apoptosis under conditions in which PKA-mediated protein phosphorylation is completely blocked. Second, sustained β 1 AR stimulation elicits PKA-independent augmentation of intracellular Ca 2+ as well as SR Ca 2+
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Figure 5
Role of CaMKII and calcineurin in the β 1 AR-mediated apoptotic effect. After β 1 β 2 DKO myocytes were infected by Adv-β 1 AR, cells were pretreated with the CaMKII inhibitors AIP (10 µM) or KN93 (0.5 µM) or the inactive KN93 analogue KN92 (2 µM); with the calcineurin inhibitors FK506 (10 µM) or cyclosporin A (5 µM); with the PKA inhibitor PKI (5 µM); or with the Ca 2+ channel block-load in both resting and electrically paced myocytes, and CaMKII is activated in a time-dependent fashion. More importantly, either blocking I Ca , buffering intracellular Ca 2+ , or inhibiting CaMKII activity fully protects cardiac myocytes against β 1 AR-induced apoptosis. The essential role of CaMKII in β 1 AR apoptotic signaling is also corroborated by the fact that overexpression of a cardiac isoform of CaMKII, CaMKII-δC, markedly enhances β 1 AR-induced apoptosis. Similarly, in cultured adult rat cardiac myocytes, β 1 AR-mediated apoptosis is blocked by nifedipine or CaMKII inhibition with KN93, but not by PKA inhibition with PKI (data not shown). Thus, we conclude that the β 1 AR-evoked apoptotic signal is delivered by a PKA-independent, CaMKII-mediated signaling pathway. Nevertheless, this should not be taken as evidence that basal CaMKII activation (such as in the beating heart) alone is sufficient to induce apoptosis. Our previous studies have shown that 2.0-Hz electrical pacing is able to augment CaMKII activation, as shown by a twofold increase in CaMKII-dependent phosphorylation of PLB at Thr 17 , and that the effect of pacing on PLB-Thr 17 phosphorylation is synergistically enhanced to sixfold when combined with β 1 AR stimulation in freshly isolated rat cardiac myocytes (38) , indicating that β 1 AR stimulation and electrical pacing exert a synergistic effect on CaMKII activation in cardiac myocytes. Although unexpected, the present finding that the β 1 AR apoptotic effect is PKA-independent is supported by previous observations that transgenic overexpression of adenylyl cyclase and the resultant elevation of intracellular cAMP in mouse hearts are dissociated from myocyte apoptosis (14, 15) , and that β 2 AR stimulation exhibits a profound antiapoptotic effect despite elevated intracellular cAMP formation in cardiac myocytes (3) (4) (5) 16) . Together, the present and previous studies indicate that an increase in cAMP/PKA signaling does not necessarily cause heart cell apoptosis. This perhaps reflects distinct compartmentation of intracellular cAMP under different circumstances (2, 26, 39-42 ). In contrast, the linkage of sustained β 1 AR stimulation to cardiac myocyte apoptosis by the multifunctional protein kinase, CaMKII, is in general agreement with recent findings that, in naive cell lines, numerous insulting factors including UV light, TNF-α (43), and protein phosphatase inhibitors (44) activates the cAMP/PKA pathway, with the peak response within 1 minute (45), whereas prolonged β 1 AR stimulation causes desensitization of cAMP/ PKA signaling within 30 minutes (1, 24) . This fast cAMP/PKA response is crucial to sympathetic control over the heart rate and myocardial contraction, allowing the heart to increase its output within seconds in response to a "fight-or-flight" situation. In contrast, the newly identified CaMKII signaling is evoked gradually and appears to contribute little to acute β 1 AR contractile response, but is essential to the β 1 AR cardiac apoptotic effect. The slow kinetics of CaMKII activation may reflect a cumulative increase in intracellular Ca 2+ due to a small but persistent Ca 2+ entry through L-type channels. This interpretation is consistent with the facts that CaMKII activation is blocked by the L-type channel antagonist niphedipine and that CaMKII-δC is enriched beneath cell surface membranes, thus permitting an intimate interplay between CaMKII and the L-type channel (23) . Alternatively, the gradual elevation of CaMKII activity may reflect that multiple steps, e.g., upregulation of intermediate signaling components, are involved in transducing receptor signal to the kinase activation.
Regardless of the exact mechanism, the time-dependent switch of signaling modes during enduring receptor stimulation may represent a new paradigm of G protein-coupled receptor signal transduction. In this regard, it has recently been shown that β 2 AR stimulation induces a switch from cAMP/PKA signaling to a G i -dependent MAPK signaling pathway (46) , and that these two events are causally linked, i.e., activation of cAMP/PKA is a prerequisite for the receptor coupling to G i proteins and the subsequent activation of the MAPK pathway (46) . In the case for sustained β 1 AR stimulation, however, the gradual activation of CaMKII is independent of PKA signaling ( Figure 6 ). Both examples show a time-dependent homologous regulation of G protein-coupled receptor signaling.
Regarding possible mechanisms underlying the non-PKA-dependent increase in intracellular Ca 2+ , it has been proposed that persistent β 1 AR stimulation increases I Ca via a direct coupling of G sα to the Ca 2+ channel (47) . More recently, it has been shown that cardiac-specific overexpression of G sα similarly augments I Ca amplitude in a PKA-independent manner (48) . Both lines of evidence support the idea that PKA-independent cross-talk between G sα and the L-type Ca 2+ channel may contribute to β 1 AR-induced increase in intracellular Ca 2+ and subsequent activation of CaMKII.
Pathophysiological relevance of β 1 AR apoptotic signaling. Increasing evidence indicates that prolonged β 1 AR stimulation exerts a cardiotoxic effect that often outweighs the short-term gain in cardiac contractile support. Both in vivo and in vitro studies have shown that enhanced β 1 AR signaling by either selective receptor stimulation or receptor overexpression increases proapoptotic protein levels and promotes cardiac apoptosis (3-6). Since cardiac myocytes are terminally differentiated cells, preventing the loss of irreplaceable cells is critical for the maintenance of normal cardiac function. These studies explain, at least in part, the poor prognosis of heart failure patients with tonically elevated plasma norepinephrine, an endogenous β 1 AR agonist (49) , as well as the beneficial effects of βAR blockers, particularly β 1 AR blockers in chronic heart failure (50) . In light of the present findings, an increase in intracellular Ca 2+ and subsequent activation of CaMKII, rather than the long-suspected cAMP/PKA cascade, are particularly cardiotoxic in terms of cardiac myocyte apoptosis. Thus, unraveling the new pathway and the novel signaling mode of β 1 AR signal transduction hold promise for identifying key therapeutic targets and new strategies for minimizing detrimental effects of β 1 AR stimulation in the failing heart.
